日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responses

利用纳米颗粒递送前药激活细菌酶可诱导抗肿瘤反应

Sebastian G Huayamares ,Liming Lian ,Regina Rab ,Yuning Hou ,Afsane Radmand ,Hyejin Kim ,Ryan Zenhausern ,Bhagelu R Achyut ,Melissa Gilbert Ross ,Melissa P Lokugamage ,David Loughrey ,Hannah E Peck ,Elisa Schrader Echeverri ,Alejandro J Da Silva Sanchez ,Aram Shajii ,Andrea Li ,Karen E Tiegreen ,Philip J Santangelo ,Eric J Sorscher ,James E Dahlman

Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females.

女性自然杀伤细胞对LKB1突变型肺腺癌的抑制作用

Fan Yijian, Jin Rui, Monterroza Lenore, Liu Xiuju, Huang Chunzi, Marra Angelo, Mo Xiulei, Fu Haian, Gilbert-Ross Melissa, Marcus Adam I, Tirouvanziam Rabindra, Liu Yuan, Schneider Frank, Zhou Wei

High PER1 expression is associated with STK11 mutation and clinical biomarkers of immunotherapy resistance in lung adenocarcinoma.

PER1 高表达与 STK11 突变和肺腺癌免疫治疗耐药的临床生物标志物相关

Parker Rebecca E, McSwain Leon, Zhou Wei, Marcus Adam I, Fu Haian, Ramalingam Suresh S, Zhang Shirley, Gilbert-Ross Melissa

Protective efficacy of emodin in Swiss Albino mice induced with Dalton Ascitic lymphoma

大黄素对诱导达尔顿腹水淋巴瘤的瑞士白化小鼠的保护作用

Joel, Jesse; Kolla, Harish Babu; Vemuri, Sai Rupini; Suluvoy, Jagadish Kumar; Balasubramanian, Avany; Rex, Gilbert Ross; Reddy, Prakash Narayana; Koigoora, Srikanth

Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer

活细胞侵袭性表型分析揭示 ALK2 是 LKB1 突变型肺癌的治疗靶点

Junghui Koo, Chang-Soo Seong, Rebecca E Parker, Amy Herrera, Bhakti Dwivedi, Robert A Arthur, Ashok Reddy Dinasarapu, Henry Richard Johnston, Henry Claussen, Carol Tucker-Burden, Suresh S Ramalingam, Haian Fu, Wei Zhou, Adam I Marcus #, Melissa Gilbert-Ross #

Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981

肿瘤内YAP和TAZ异质性驱动非小细胞肺癌的集体侵袭,而SUMO化抑制剂TAK-981正是针对这种侵袭。

Richa Sharma ,Shagun Sharma ,Pratik Shriwas ,Labdhi Mehta ,An H Vu ,Janna K Mouw ,Junghui Koo ,Chunzi Huang ,Veronika Y Matsuk ,Carol Tucker-Burden ,Gregory Joseph ,Madhusmita Behera ,Shi-Yong Sun ,Melissa A Roy ,Melissa Gilbert-Ross ,Ticiana Leal ,Adam I Marcus ,Mala Shanmugam

Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin αvβ1 and FAK

早期肺癌肿瘤微环境中的 Tenascin-C 通过整合素 αvβ1 和 FAK 促进进展

Shiela C Samson, Anthony Rojas, Rebecca G Zitnay, Keith R Carney, Wakeiyo Hettinga, Mary C Schaelling, Delphine Sicard, Wei Zhang, Melissa Gilbert-Ross, Grace K Dy, Michael J Cavnar, Muhammad Furqan, Robert F Browning Jr, Abdul R Naqash, Bryan P Schneider, Ahmad Tarhini, Daniel J Tschumperlin, Aless

Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient-derived xenografts

评价大肠杆菌嘌呤核苷磷酸化酶对头颈部患者来源异种移植瘤的抗肿瘤活性

Rab, Regina; Ehrhardt, Annette; Achyut, Bhagelu R; Joshi, Disha; Gilbert-Ross, Melissa; Huang, Chunzi; Floyd, Katharine; Borovjagin, Anton V; Parker, William B; Sorscher, Eric J; Hong, Jeong S

Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer

活细胞侵袭性表型分析揭示 ALK2/BMP6 铁稳态通路是 LKB1 突变型肺癌治疗的一个弱点

Junghui Koo, Chang-Soo Seong, Rebecca E Parker, Bhakti Dwivedi, Robert A Arthur, Ashok Reddy Dinasarapu, H Richard Johnston, Henry Claussen, Carol Tucker-Burden, Suresh S Ramalingam, Haian Fu, Wei Zhou, Adam I Marcus, Melissa Gilbert-Ross

Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis

内吞肿瘤抑制因子HD-PTP的缺失会模拟LKB1的表型,并促进RAS驱动的肿瘤发生。

Seong, Chang-Soo; Huang, Chunzi; Boese, Austin C; Hou, Yuning; Koo, Junghui; Mouw, Janna K; Rupji, Manali; Joseph, Greg; Johnston, H Richard; Claussen, Henry; Switchenko, Jeffrey M; Behera, Madhusmita; Churchman, Michelle; Kolesar, Jill M; Arnold, Susanne M; Kerrigan, Katie; Akerley, Wallace; Colman, Howard; Johns, Margaret A; Arciero, Cletus; Zhou, Wei; Marcus, Adam I; Ramalingam, Suresh S; Fu, Haian; Gilbert-Ross, Melissa